Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California - Wikidata - wikimedia - TriplyDB

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California

http://www.wikidata.org/entity/Q33978978

about

HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil The hepatitis C cascade of care: identifying priorities to improve clinical outcomes Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.Usefulness of Dried Blood Spots (DBS) to perform hepatitis C virus genotyping in drug users in Senegal.The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.

P2860

Q28538943-DD240BA2-4B2F-4464-9504-04A077CE84CB Q33632459-39FEECF3-B3EA-4853-806E-0DB521F9A296 Q33648185-6AE55945-B090-4CD6-BC27-85F50668BA8A Q34735072-2F28FCA6-60B9-4720-9A57-0D7502D8A103 Q35572125-0CA85B3D-684D-48F7-B82C-35BC3EC675A0 Q35765985-72046CEB-242C-42C7-9773-789C2B0B069D Q38381584-F93841B6-6ED7-4B0E-969A-7B7A2441A939 Q38665087-6459AE4A-D3CB-47CD-8677-999A3D258905 Q40857029-D551E147-92A4-44C0-9EEB-D4F917C38043 Q41919051-F28E5F3B-0E5A-4702-A1A4-DB83699BCE09 Q47274792-0418E629-C6B3-457D-A0B2-E9DAB46788A7

P2860

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California

http://www.wikidata.org/entity/Q33978978

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Temporal changes in HCV genoty ...... s in San Francisco, California

@ast

Temporal changes in HCV genoty ...... s in San Francisco, California

@en

type

label

Temporal changes in HCV genoty ...... s in San Francisco, California

@ast

Temporal changes in HCV genoty ...... s in San Francisco, California

@en

prefLabel

Temporal changes in HCV genoty ...... s in San Francisco, California

@ast

Temporal changes in HCV genoty ...... s in San Francisco, California

@en

P1433

Q33978978-0A15405B-1C05-4C46-93CD-748E6E3055C5

P1476

Q33978978-0539234E-E127-41D4-BA8B-202C7A46FA22

P2093

Q33978978-002EF4DA-4F9D-46BF-AEF3-EA33B932B302

Q33978978-4574C17D-D20E-4A54-B19A-0882933477F9

Q33978978-6749CF8B-153E-4FE4-BAF5-29968290352F

Q33978978-8CC3E526-4088-4304-85C1-8CC72FD4BC8D

Q33978978-A2F3A9B5-2D2E-4A00-8D85-BA1A95473933

Q33978978-D267FED5-A903-42E2-90A5-CC93799C91EB

Q33978978-D7D8C02C-6094-4CD2-BC24-D82ECD9CA054

P2860

Q33978978-007D07D1-2047-4840-B9F9-8008806B590A

Q33978978-0196D806-DA46-41DB-A34D-D8F1AF3ECF90

Q33978978-02B91EF9-49A4-4809-8C8C-C9BC2C5A2C09

Q33978978-02EF29CF-00E1-43DD-995B-568171662E5D

Q33978978-071C4B6C-7939-45E7-A02C-1725BE4C35D1

Q33978978-07CD5AC5-F1A4-48DC-ABC5-B8974ACC3BFA

Q33978978-0AFF33D9-3AE4-429E-8776-9BB56BA0A9C4

Q33978978-0E3F75EB-19A3-4C33-B6A3-430E43EC786E

Q33978978-0F738DE7-EF1F-4385-AEB9-84FE3BE67E3E

Q33978978-260DFC1C-F42A-4760-B6FF-F652C9AB8F6C

P2888

Q33978978-61AC1DB1-2C47-40D6-AFEE-D0C772AA2322

P304

Q33978978-A5693C07-196C-452B-9257-307902988895

P31

Q33978978-0D88CB95-D378-4C86-B4EB-FD3A062D9356

P356

Q33978978-E54A8FF0-2DFE-4ACB-B8B5-259472A5C987

P478

Q33978978-9A715C4B-4F40-4178-B0EB-AB047A3B54ED

P50

Q33978978-0402985D-2D21-4D53-8894-F771E1DBE50A

Q33978978-6E14EB9B-E567-406B-B681-E8A99959569A

Q33978978-BB3A456B-AA6B-45A7-89C7-45CE017A723B

Q33978978-D7905879-2049-499A-A52B-5F177242FAC1

P577

Q33978978-ADD8349D-4A4D-451D-B892-4A4E29D9EAF9

P5875

Q33978978-D87216DE-EBD3-4077-B1BC-ACDC4B1DFFB4

P6179

Q33978978-CB562E1A-0072-4B15-B0D0-CED77C3C1618

P698

Q33978978-4E2BF5AA-3A18-4C14-806F-DD288ABFC2BA

P921

Q33978978-66C1CD17-A647-406A-A56D-F5B195806D72

Q33978978-F4660583-D95F-4764-B261-D1F2A191ACD4

P932

Q33978978-F38C0C72-6442-4AF6-AB28-375447D1BC71

P356

1471-2334-11-208

P1433

BMC Infectious Diseases

P1476

Temporal changes in HCV genoty ...... s in San Francisco, California

@en

P2093

Alex Kral

http://www.w3.org/2001/XMLSchema#string

Jeff Martin

http://www.w3.org/2001/XMLSchema#string

Jennifer Evans

http://www.w3.org/2001/XMLSchema#string

Judith A Hahn

http://www.w3.org/2001/XMLSchema#string

Paula Lum

http://www.w3.org/2001/XMLSchema#string

Paulo Telles Dias

http://www.w3.org/2001/XMLSchema#string

Steve Deeks

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users.

Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis

Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection

P2888

1471-2334-11-208

P304

208

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-11-208

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Busch

P577

2011-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51541308

http://www.w3.org/2001/XMLSchema#string

P6179

1041870297

http://www.w3.org/2001/XMLSchema#string

P698

21810243

http://www.w3.org/2001/XMLSchema#string

P921

P932

3199778

http://www.w3.org/2001/XMLSchema#string